Pulmonary Involvement in Microscopic Polyangiitis: Computed Tomography Findings in 55 Patients With Analysis of Risk

Takeshi Saraya1, Yukari Ogawa1, Keitaro Nakamoto1

  • 1Respiratory Medicine, Kyorin University School of Medicine, Mitaka, JPN.

Cureus
|February 21, 2022
PubMed

Insights

Microscopic polyangiitis (MPA) often involves the lungs, with CT scans showing ground glass opacities and reticular shadowing. A high white blood cell (WBC) count may predict early systemic recurrence in MPA patients.

Area of Science:

  • Pulmonology
  • Radiology
  • Rheumatology

Background:

  • Pulmonary involvement occurs in up to 30% of microscopic polyangiitis (MPA) patients.
  • Radiological findings in MPA-related lung disease are not well-documented.
  • This study investigates CT findings and clinical data as predictors of MPA recurrence.

Purpose of the Study:

  • To evaluate computed tomography (CT) findings at diagnosis.
  • To assess clinical features as predictors of systemic or lung recurrence in MPA patients with pulmonary involvement.

Main Methods:

  • Retrospective review of medical records and radiological data from 55 MPA patients.
  • Analysis of pulmonary and extrapulmonary lesions, biopsy results, and CT findings.
  • Cox regression analysis to identify predictors of recurrence.

Main Results:

  • Pulmonary lesions were common, with parenchymal opacities (ground-glass, reticular shadowing) more frequent than airway abnormalities (bronchiectasis).
  • Systemic recurrence occurred in 10.9% within one year, primarily affecting kidneys or lungs.
  • A serum WBC count ≥ 10,900/μL was a significant risk factor for systemic recurrence within the first year (HR 11.1, p=0.028).
  • Lung recurrence was observed in 9.1% within five years; reticular shadowing and honeycombing were more frequent in recurrent cases but not predictive.

Conclusions:

  • Prominent thoracic CT findings in MPA include ground glass opacities, reticular shadowing, and bronchiectasis.
  • No specific radiological patterns on CT effectively predict MPA recurrence.
  • A serum WBC count ≥ 10,900/μL at diagnosis may predict systemic recurrence within one year.

Related Concept Videos

Radiological Investigation III: Pulmonary Angiogram and PET Scan01:13

Radiological Investigation III: Pulmonary Angiogram and PET Scan

Radiological investigations are paramount in the diagnosis and management of various pulmonary diseases. Two essential investigations are the Pulmonary Angiogram and the Positron Emission Tomography (PET) Scan.
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...
182
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
219
Pneumothorax-II01:27

Pneumothorax-II

Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
435
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
60
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
552
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
491